Home › Companies › Bio-Rad Laboratories, Inc. › 2024-2025

Bio-Rad Laboratories, Inc. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and Bio-Rad Laboratories, Inc.’s Form 8-K, filed 2025-04-25 (Item 5.07 on EDGAR). Page generated 02 October 2026.

10Reported items
133Asset managers
1,660Fund votes
2025-04-22Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Bio-Rad Laboratories, Inc. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by Bio-Rad Laboratories, Inc.

These tallies are Bio-Rad Laboratories, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-04-25 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Bio-Rad Laboratories, Inc. — official shareholder meeting results, meeting held 2025-04-22
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Melinda Litherland	16,693,588	3,918,478	10,596	--	1,195,004	Majority: yes
Elect Director: Arnold A. Pinkston	17,013,765	3,598,331	10,566	--	1,195,004	Majority: yes
Elect Director: Jeffrey L. Edwards	4,989,577	341	91	--	33,701	Majority: yes
Elect Director: Gregory K. Hinckley	4,989,577	341	91	--	33,701	Majority: yes
Elect Director: Allison Schwartz	4,988,465	1,453	91	--	33,701	Majority: yes
Elect Director: Norman Schwartz	4,988,465	1,453	91	--	33,701	Majority: yes

Source: Bio-Rad Laboratories, Inc., Form 8-K, filed with the SEC on 2025-04-25 — read the filing on EDGAR.

How asset managers voted at the Bio-Rad Laboratories, Inc. 2024-2025 meeting

Each item below shows how the 133 asset managers that disclosed a Bio-Rad Laboratories, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Bio-Rad Laboratories, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Nominees: Arnold A. Pinkston

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST 17%

FOR: 17,013,765AGAINST: 3,598,331

Bio-Rad Laboratories, Inc.’s own tally for this item (“Elect Director: Arnold A. Pinkston”): 17,013,765 for, 3,598,331 against, per its Form 8-K filed 2025-04-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 27,941,000 outstanding shares: 61% for, 13% against (74% of the company cast a for/against vote).

The 121 asset managers below cast 77% of the shares they voted on this item FOR (6,700,358 for, 1,972,796 against).

FOR 77%AGAINST 23%

FOR: 6,700,358 (77.2%)AGAINST: 1,972,796 (22.7%)ABSTAIN: 3,601 (0.0%)

Largest asset managers voting on “Nominees: Arnold A. Pinkston” at Bio-Rad Laboratories, Inc., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	1,909,238	0	0	For
VanEck ETF Trust	0	1,134,115	0	Against
FIRST EAGLE FUNDS	1,052,856	0	0	For
BlackRock	873,408	0	0	For
Dimensional	656,415	0	0	For
ARIEL INVESTMENT TRUST	353,143	0	0	For
Fidelity	308,320	12,353	0	For
Parnassus	0	318,111	0	Against
LONGLEAF PARTNERS FUNDS TRUST	202,896	0	0	For
Charles Schwab	0	195,069	0	Against
Investment Managers Series Trust III	157,118	0	0	For
State Street	1,968	127,498	0	Against
Jackson National	128,441	0	0	For
Allspring	121,123	0	0	For
John Hancock	111,357	0	0	For
Transamerica	104,377	0	0	For
HARBOR FUNDS	70,153	0	0	For
Putnam	0	59,707	0	Against
Equitable	27,990	22,878	0	For
Artisan	48,018	0	0	For
TRUST FOR PROFESSIONAL MANAGERS	43,082	0	0	For
FRANKLIN VALUE INVESTORS TRUST	0	41,406	0	Against
Gabelli	40,300	0	0	For
Brighthouse	34,773	0	3,601	For
TIAA	37,982	0	0	For

Showing the 25 largest of 121 asset managers. See all 121 in the interactive database.

2. Nominees: Melinda Litherland

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%AGAINST 19%

FOR: 16,693,588AGAINST: 3,918,478

Bio-Rad Laboratories, Inc.’s own tally for this item (“Elect Director: Melinda Litherland”): 16,693,588 for, 3,918,478 against, per its Form 8-K filed 2025-04-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 27,941,000 outstanding shares: 60% for, 14% against (74% of the company cast a for/against vote).

The 121 asset managers below cast 74% of the shares they voted on this item FOR (6,431,397 for, 2,241,757 against).

FOR 74%AGAINST 26%

FOR: 6,431,397 (74.1%)AGAINST: 2,241,757 (25.8%)ABSTAIN: 3,601 (0.0%)

Largest asset managers voting on “Nominees: Melinda Litherland” at Bio-Rad Laboratories, Inc., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	1,909,238	0	0	For
VanEck ETF Trust	0	1,134,115	0	Against
FIRST EAGLE FUNDS	1,052,856	0	0	For
BlackRock	873,408	0	0	For
Dimensional	656,415	0	0	For
ARIEL INVESTMENT TRUST	353,143	0	0	For
Fidelity	39,359	281,314	0	Against
Parnassus	0	318,111	0	Against
LONGLEAF PARTNERS FUNDS TRUST	202,896	0	0	For
Charles Schwab	0	195,069	0	Against
Investment Managers Series Trust III	157,118	0	0	For
State Street	1,968	127,498	0	Against
Jackson National	128,441	0	0	For
Allspring	121,123	0	0	For
John Hancock	111,357	0	0	For
Transamerica	104,377	0	0	For
HARBOR FUNDS	70,153	0	0	For
Putnam	0	59,707	0	Against
Equitable	27,990	22,878	0	For
Artisan	48,018	0	0	For
TRUST FOR PROFESSIONAL MANAGERS	43,082	0	0	For
FRANKLIN VALUE INVESTORS TRUST	0	41,406	0	Against
Gabelli	40,300	0	0	For
Brighthouse	34,773	0	3,601	For
TIAA	37,982	0	0	For

Showing the 25 largest of 121 asset managers. See all 121 in the interactive database.

3. Stockholder proposal requesting approval of certain executive severance arrangements.

COMPENSATION

Combines 3 wordings of this item as funds reported it.

41% fund support · no official result

FOR 41%AGAINST 59%

The 119 asset managers below cast 41% of the shares they voted on this item FOR (3,582,721 for, 5,082,272 against).

FOR: 3,582,721 (41.3%)AGAINST: 5,082,272 (58.6%)ABSTAIN: 3,601 (0.0%)

Largest asset managers voting on “Stockholder proposal requesting approval of certain executive severance arrangements.” at Bio-Rad Laboratories, Inc., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	0	1,909,238	0	Against
VanEck ETF Trust	1,134,115	0	0	For
FIRST EAGLE FUNDS	3,473	1,049,383	0	Against
BlackRock	0	873,408	0	Against
Dimensional	656,415	0	0	For
ARIEL INVESTMENT TRUST	0	353,143	0	Against
Fidelity	306,589	14,084	0	For
Parnassus	318,111	0	0	For
LONGLEAF PARTNERS FUNDS TRUST	0	202,896	0	Against
Charles Schwab	0	195,069	0	Against
Investment Managers Series Trust III	157,118	0	0	For
State Street	1,955	127,511	0	Against
Jackson National	4,954	123,487	0	Against
Allspring	121,123	0	0	For
John Hancock	111,357	0	0	For
Transamerica	104,377	0	0	For
HARBOR FUNDS	70,153	0	0	For
Putnam	59,707	0	0	For
Equitable	22,878	27,990	0	Against
Artisan	48,018	0	0	For
TRUST FOR PROFESSIONAL MANAGERS	42,752	330	0	For
FRANKLIN VALUE INVESTORS TRUST	41,406	0	0	For
Gabelli	0	40,450	0	Against
Brighthouse	34,773	0	3,601	For
TIAA	37,982	0	0	For

Showing the 25 largest of 119 asset managers. See all 119 in the interactive database.

4. Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors.

AUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 116 asset managers below cast 99.9% of the shares they voted on this item FOR (8,651,263 for, 6 against).

FOR: 8,651,263 (100.0%)AGAINST: 6 (0.0%)ABSTAIN: 3,601 (0.0%)

Largest asset managers voting on “Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors.” at Bio-Rad Laboratories, Inc., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	1,909,238	0	0	For
VanEck ETF Trust	1,134,115	0	0	For
FIRST EAGLE FUNDS	1,052,856	0	0	For
BlackRock	873,408	0	0	For
Dimensional	656,415	0	0	For
ARIEL INVESTMENT TRUST	353,143	0	0	For
Fidelity	320,673	0	0	For
Parnassus	318,111	0	0	For
LONGLEAF PARTNERS FUNDS TRUST	202,896	0	0	For
Charles Schwab	195,069	0	0	For
Investment Managers Series Trust III	157,118	0	0	For
State Street	129,460	6	0	For
Jackson National	128,441	0	0	For
Allspring	121,123	0	0	For
John Hancock	111,357	0	0	For
Transamerica	104,377	0	0	For
HARBOR FUNDS	70,153	0	0	For
Putnam	59,707	0	0	For
Equitable	50,868	0	0	For
Artisan	48,018	0	0	For
TRUST FOR PROFESSIONAL MANAGERS	43,082	0	0	For
FRANKLIN VALUE INVESTORS TRUST	41,406	0	0	For
Gabelli	40,450	0	0	For
Brighthouse	34,773	0	3,601	For
TIAA	37,982	0	0	For

Showing the 25 largest of 116 asset managers. See all 116 in the interactive database.

5. Submit Severance Agreement to Shareholder Vote

SECTION 14A SAY-ON-PAY VOTES

18% fund support · no official result

FOR 18%AGAINST 82%

The 8 asset managers below cast 18% of the shares they voted on this item FOR (58,353 for, 258,783 against).

FOR: 58,353 (18.4%)AGAINST: 258,783 (81.6%)

Largest asset managers voting on “Submit Severance Agreement to Shareholder Vote” at Bio-Rad Laboratories, Inc., 2024-2025
Asset manager	For	Against	Vote
SOUTHEASTERN ASSET MANAGEMENT INC/TN/	0	249,849	Against
Bellevue Group AG	34,907	0	For
Hosking Partners LLP	12,558	0	For
Empower	9,951	689	For
GreenFi Funds Trust	0	8,245	Against
HC CAPITAL TRUST	398	0	For
CLEARWATER INVESTMENT TRUST	300	0	For
GuideStone	239	0	For

6. Ratify KPMG LLP as Auditors

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 5 asset managers below cast 100% of the shares they voted on this item FOR (19,822 for, 0 against).

FOR: 19,822 (100.0%)

Largest asset managers voting on “Ratify KPMG LLP as Auditors” at Bio-Rad Laboratories, Inc., 2024-2025
Asset manager	For	Vote
Empower	10,640	For
GreenFi Funds Trust	8,245	For
HC CAPITAL TRUST	398	For
CLEARWATER INVESTMENT TRUST	300	For
GuideStone	239	For

7. Ratify Appointment of Independent Auditors

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (3,221 for, 0 against).

FOR: 3,221 (100.0%)

Largest asset managers voting on “Ratify Appointment of Independent Auditors” at Bio-Rad Laboratories, Inc., 2024-2025
Asset manager	For	Vote
Cardano Risk Management B.V.	2,213	For
WILLIAMSBURG INVESTMENT TRUST	1,000	For
Simplify Exchange Traded Funds	8	For

8. Election of Directors (Majority Voting)

DIRECTOR ELECTIONS

All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR.

FOR: 100.0%

Largest asset managers voting on “Election of Directors (Majority Voting)” at Bio-Rad Laboratories, Inc., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
WILLIAMSBURG INVESTMENT TRUST	1,000	0	0	0	For
Simplify Exchange Traded Funds	8	0	0	0	For

9. S/H Proposal - Corporate Governance

INVESTMENT COMPANY MATTERS

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (18,008 for, 0 against).

FOR: 18,008 (100.0%)

Largest asset managers voting on “S/H Proposal - Corporate Governance” at Bio-Rad Laboratories, Inc., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
WILLIAMSBURG INVESTMENT TRUST	18,000	0	0	0	For
Simplify Exchange Traded Funds	8	0	0	0	For

10. Shareholder Proposal Regarding Severance Approval Policy

COMPENSATION

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (2,283 for, 0 against).

FOR: 2,283 (100.0%)

Largest asset managers voting on “Shareholder Proposal Regarding Severance Approval Policy” at Bio-Rad Laboratories, Inc., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Cardano Risk Management B.V.	2,213	0	0	0	For
OSSIAM	70	0	0	0	For

Largest Bio-Rad Laboratories, Inc. shareholders voting in 2024-2025

Ranked by the number of Bio-Rad Laboratories, Inc. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 27,941,000 shares outstanding at the time of that meeting.

Top Bio-Rad Laboratories, Inc. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	Vanguard	6.83%
2	VanEck ETF Trust	4.06%
3	FIRST EAGLE FUNDS	3.77%
4	BlackRock	3.13%
5	Dimensional	2.35%
6	ARIEL INVESTMENT TRUST	1.26%
7	Fidelity	1.15%
8	Parnassus	1.14%
9	LONGLEAF PARTNERS FUNDS TRUST	0.73%
10	Charles Schwab	0.70%

Reported Bio-Rad Laboratories, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Bio-Rad Laboratories, Inc. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
Norman D. Schwartz	11.56%	13D
BIO-RAD LABORATORIES, INC	9.89%	13G
Alice N. Schwartz	9.78%	13D
BlackRock	7.24%	13F
Vanguard Group	6.84%	13F
Dimensional Fund Advisors	3.14%	13F
State Street	2.49%	13F
Geode Capital	1.23%	13F
Millennium Management	1.20%	13F
Northern Trust	0.93%	13F

Percentages above are of 27,941,000 shares outstanding, as reported by Bio-Rad Laboratories, Inc. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Bio-Rad Laboratories, Inc.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Bio-Rad Laboratories, Inc.'s shareholder meeting held 2025-04-22, in the 2024-2025 proxy season, 133 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,660 separate fund positions. Their filings are grouped here into 10 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Nominees: Arnold A. Pinkston — FOR was 83% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Bio-Rad Laboratories, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-04-25.

Bio-Rad Laboratories, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.